Menkes International · About Us

Copper(less) Committee

MIA's scientific advisory body, established March 2021. A multidisciplinary team of scientists, physicians, pharmacists and families working pro bono.

Mission

The Copperless Committee is the scientific advisory board (SAB) of Menkes International (MICu). It was created in March 2021 to develop the first human dosing plan for the exceptional treatment with elesclomol-copper (Es-Cu) for Marco, the first Menkes patient to receive this new drug.

The Committee brings together scientists, researchers, medical doctors, biochemists, pharmacometricians, pharmacologists, chemists, biologists, therapists and patient families — all recognised experts serving pro bono, in their individual capacity. It advances research, provides clinical guidance, and fosters international collaboration to improve treatment outcomes for Menkes disease and other rare copper-related disorders, including:

  • Named-Patient Programs (NPP-Menkes), such as elesclomol-copper for duly authorised patients;
  • Early diagnosis protocols and related instruments;
  • Ongoing research initiatives on Menkes disease and other rare copper disorders;
  • New collaborative projects;
  • Advocacy for awareness and treatment accessibility;
  • Training and education for families, clinicians and the wider community.

Committee Members — Census 2026

Bureau
Francesc Palau

Francesc Palau

Chair

Pediatrician & Medical Geneticist, CSIC Research Professor · SJD Distinguished Investigator, Sant Joan de Déu Hospital and Research Institute

Barcelona, Spain

VG

Vishal Gohil

Vice-Chair

Professor, Biochemistry & Biophysics

Texas A&M University, College Station, TX, USA

Denis Broun

Denis Broun

Rapporteur

Medical Director, Menkes International · Former WHO and World Bank Director · CEO, Givopax

Aurora Mateos

Aurora Mateos

Secretary

Founder & President, Menkes International – Copper Rare Foundation

Málaga, Spain

FR

Flor Rolleri

Technical Secretary

Medical Doctor, Servicio Valenciano de Salud · Menkes International – Copper Rare Foundation

Council Members
Zeynep Asuman

Zeynep Asuman

Clinical Professor, Kennedy Center, Dept. of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark

Mercè Capdevila

Mercè Capdevila

Professor of Inorganic Chemistry, Universitat Autònoma de Barcelona

Kay Double

Kay Double

Professor, Brain and Mind Centre, School of Medical Sciences

Sydney, Australia

Elena Godoy

Elena Godoy

Coordinator

Attending Pediatrician, Complex Chronic Children and Palliative Care Unit, Regional University Hospital

Málaga, Spain

Janet Hoenicka

Janet Hoenicka

Senior Investigator, Sant Joan de Déu Research Institute

Nina Horn

Nina Horn

Professor (rtd), Menkes researcher · Pharmacist Director (rtd), Kennedy Center–Copenhagen University Hospital

Svetlana Lutsenko

Svetlana Lutsenko

Professor, Associate Director for Basic Science and Clinical Relations, Institute for Basic Biomedical Sciences, Johns Hopkins University

Baltimore, USA

Victor Mangas

Victor Mangas

Assistant Professor, University of Valencia · Specialist in Pharmacometrics, Pharmacokinetics, Bioequivalence

Valencia, Spain

Michael Petris

Michael Petris

Professor of Biochemistry, Menkes researcher, University of Missouri – School of Medicine

Columbia, MO, USA

Jim Sacchettini

Jim Sacchettini

Rodger J. Wolfe-Welch Foundation Chair, Professor of Biochemistry & Biophysics, Chemistry, Texas A&M University

College Station, TX, USA

Natalia Serrano

Natalia Serrano

Medical Director, Engrail Therapeutics

Barcelona, Spain

Joseph Standing

Joseph Standing

Professor of Pharmacometrics, UCL Institute of Child Health · Honorary Research Pharmacist, Great Ormond Street Hospital

London, UK

Steffen Syrbe

Steffen Syrbe

Senior Physician, Director, Section of Neuropediatrics and Metabolic Medicine, Heidelberg University Clinic

Heidelberg, Germany

Prachi Trivedi

Prachi Trivedi

Associate Research Scientist, Dept. of Biochemistry & Biophysics, Texas A&M University

College Station, TX, USA

Board Members
YH

Yusuf Hamied

Chemist & Philanthropist, CEO, CIPLA Therapeutics

Elisabeth de Lange

Elisabeth de Lange

Professor in Predictive Pharmacology, Division of Systems Biomedicine and Pharmacology, LACDR, Leiden University · President, Dutch Pharmacological Society

Leiden, The Netherlands

Diego Martinelli

Diego Martinelli

Head of the Metabolic Section, Bambino Gesù Hospital

Julian Mercer

Julian Mercer

Professor Emeritus, Deakin University · Director, Centre for Cellular and Molecular Biology

Melbourne, Australia

FM

Federico Mingozzi

Chief Science & Technology Officer, Nava Therapeutics

Victoriano Mulero

Victoriano Mulero

Professor, Coordinator of the research group on immunity, inflammation and cancer, University of Murcia

Francisco Javier Otero Espinar

Francisco Javier Otero Espinar

Professor, Dept. of Pharmacy and Technology, University of Santiago de Compostela

Santiago de Compostela, Spain

Christos Papageorgiou

Christos Papageorgiou

Medical Doctor, Associate Professor, Hematology and Medical Oncology, University of Missouri

Bibudhendra Sarkar

Bibudhendra Sarkar

Senior Scientist Emeritus, Menkes researcher, SickKids Hospital

Toronto, Canada

Karin Tuschl

Karin Tuschl

MRC Clinician Scientist Fellow and Group Leader, UCL Great Ormond Street

London, UK

José Miguel Ramos Fernández

José Miguel Ramos Fernández

Chief, Dept. of Pediatric Neurology, Hospital Materno Infantil de Málaga

Málaga, Spain

CR

Cristiano Rizzo

Principal Biologist, Metabolic Diseases and Drug Biology Laboratory, Bambino Gesù Children's Hospital

Rome, Italy

Raphael Rodriguez

Raphael Rodriguez

Research Director, CNRS · Institut Curie

Paris, France

Giuseppe Ronzitti

Giuseppe Ronzitti

Team Leader, Inserm researcher, Généthon

Paris, France

Josep Suñé

Josep Suñé

Professor, University of Barcelona, Department of Pharmacy and Technology

Raquel Yahyaoui

Raquel Yahyaoui

Head, Dept. of Clinical Biochemistry · Clinical Laboratory Geneticist (EBMG), Hospital Regional Universitario de Málaga, IBIMA-Plataforma BIONAND

Core Members
Francesc Palau

Francesc Palau

Coordinator (ad interim)

Pediatrician & Clinical Geneticist, SJD Distinguished Research Fellow · Director, Institut de Recerca Hospital Sant Joan de Déu

MD

Marta Duero

Chief Pharmacist, Hospital Sant Joan de Déu

Elena Godoy

Elena Godoy

Attending Pediatrician, Complex Chronic Children and Palliative Care Unit, Regional University Hospital

Málaga, Spain

AJ

Aquilina Jiménez

Pediatrician, Dept. of Pediatric Neurology, Complejo Hospitalario de León

Rosa Marqués

Rosa Marqués

Neurological Physiotherapist, Dulce Nombre de María Psychopedagogic Institute

Málaga, Spain

Ángela Pieras

Ángela Pieras

Hospital Pharmacist (Consultant), Hospital Sant Joan de Déu

Barcelona, Spain

FR

Flor Rolleri

Core Secretary, Menkes International – Copper Rare Foundation

MS

Mónica Sáez

Hospital Pharmacist, Complejo Hospitalario de León

Rubén Varela

Rubén Varela

Hospital Pharmacist, Complejo Hospitalario de León

Miquel Villaronga

Miquel Villaronga

Hospital Pharmacist (Consultant, retired), Hospital Sant Joan de Déu

Barcelona, Spain

CopperClinic

Reference physicians and clinicians, reporting to the Copper(less) Committee

View CopperClinic